Nile tilapia piscidin 3, TP3

General Information


DRACP ID  DRACP02333

Peptide Name   Nile tilapia piscidin 3, TP3

Sequence  FIHHIIGGLFSVGKHIHSLIHGH

Sequence Length  23

UniProt ID  L0CMD2 

PubChem CID  Not available

Origin  Oreochromis niloticus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma ~80% Killing=40 µg/ml MTS assay 24 h 1
RAW 264.7 Mouse leukemia Leukemia ~60% Killing=60 µg/ml MTS assay 24 h 1

Hemolytic Activity  Human erythrocytes: 100% Hemolysis=25 µg/ml; Tilapia erythrocytes: 42% Hemolysis=100 µg/ml

Normal (non-cancerous) Cytotoxicity  TO2: 50% Cell death=80 µg/ml; MRC-5: ~50% Cell death=50 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02333

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C121H182N36O26

Absent amino acids  ACDEMNPQRTWY

Common amino acids  H

Mass  294962

Pl  9.71

Basic residues  7

Acidic residues  0

Hydrophobic residues  10

Net charge  7

Boman Index  789

Hydrophobicity  59.13

Aliphatic Index  131.3

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23226256

Title  Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions

Doi 10.1371/journal.pone.0050263

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4198

DRACP is developed by Dr.Zheng's team.